ArticleThoracic cancer2025

Safety and Efficacy of the First Subcutaneous ICI, Envafolimab, in the Treatment of Advanced Lung Cancer Patients: A Real-World Study.

Zixuan Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.